Risk Factors for Non-Hodgkin's Lymphoma

Scientists don't yet know why some people develop non-Hodgkin's lymphoma and others do not, or why a B-cell becomes cancerous and others do not.

The best they can do is determine whether there are any aspects or factors of a person with the disease that are present in other people with the disease, to the exclusion of all other such factors. By boiling down the thousands of things that we do in our lives and that we have in our genes to a solitary few things, scientists and doctors can begin to determine risk factors.

However, risk factors are very general; they aren't meant to encompass whole populations. At best, they can describe the factors that many people with the disease share and that therefore may play a role in a person developing lymphoma.

Environmental Risk Factors

Environmental risk factors for non-Hodgkin's lymphoma include:

  • Living in or working within farming communities
  • Repeated exposure to ingredients in herbicides and pesticides

Although the evidence here is epidemiologic in nature, it is relatively strong.

Click on the link to read more about environmental exposure and lymphoma.

Biological Risk Factors

Biological risk factors for non-Hodgkin's lymphoma include exposure to pathogens such as viruses and bacteria. The known pathogens include:

  • The human immunodeficiency virus (HIV)
  • The Epstein-Barr virus (EBV)
  • The human T-lymphocytotropic virus (HTLV)
  • The bacterium Helicobacter pylori, which is responsible for stomach ulcers

Click on the link to read more about viral and bacterial sources of lymphoma.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap